Table of Contents
Vaccinate Every Indian is the greater push we need at the movement against Corona Virus. Go and get your Vaccinate now!
Like Polio Dose is given at doorstep, same way ensure COVID-19 Vaccination for every Indian at doorsteps. This will generate jobs and instill a sense of confidence in the public.
India records over 1.26 lakh new COVID-19 cases, highest so far
Read @ANI Story | https://t.co/UhZzH5v9Yj pic.twitter.com/F5isT9gKzk
— ANI Digital (@ani_digital) April 8, 2021
Corona Virus Latest Update
- Today is the 380th day since India implemented a nationwide lockdown to curb the novel coronavirus epidemic.
- India recorded 1,26,789 new Covid-19 cases over 24 hours on 8 April, the highest number of daily cases since the epidemic.
- The country’s overall tally is now at 1,29,28,574, according to the data updated by the Union Health Ministry.
- As many as 685 deaths were reported across the country over the past 24 hours, taking the total coronavirus death count in India to 16,68,62.
- While 59,258 people were discharged, the total active caseload in the country is 9,10,319.
- So far, about 1,18,51,393 people have been recovered.
- The previous high of 1,03,844 new cases in a single day was reported on 5 April. Total Covid-19 vaccination stands at 9,01,98,673.
Scientists call for new investigation into COVID-19 origins
Read @ANI Story | https://t.co/XlZnoR4kQo pic.twitter.com/0dUhpIo1L2
— ANI Digital (@ani_digital) April 8, 2021
Also, read | Covid-19 survivors may affect by neurological or mental disorders
What’s the Reason for the Slow Vaccination process in India
- India has administrated 6,130 doses per 1 lakh population as of April 5, lower than the world average of 8,900 doses.
- India’s vaccination pace is relatively slower than comparable economies and Vaccinate Every Indian is the current need.
- A parliamentary committee has noted that less than 1% of the country’s population has been vaccinated against Covid-19 from February as per the information shared with it by the Ministry of Home Affairs, of the entire population.
- It will take many years to vaccinate the whole country and the corona virus may mutate more at that time.
- A proper management strategy is the need of the country to control the Corona Pandemic.
Misleading Claim related to Vaccines Creating Problem for Vaccine Drive in India
- Even after Health Ministry, any other Leaders have cleared the doubt many times that vaccine is safe still some misleading claims are been speculated related to vaccines that are hesitating people in taking vaccines.
- Impotency rumors have been circulated about vaccines like Polio several decades ago.
- Claims like Covid Vaccine in India contain Pork.
- A false claim like Vaccine contains Microchip and it will control everyone’s mood.
The country’s Health Minister, Dr. Harshvardhan has also denied this claim
#COVID19Vaccine के संदर्भ में आज @ANI से बात करते हुए मैंने कहा कि PM श्री @narendramodi जी ने स्वदेशी वैक्सीन #Covaxin लगवाकर देश को स्पष्ट संदेश दिया है व इससे संबंधित हर तरह के दुष्प्रचार को ख़त्म किया है।स्वदेशी वैक्सीन को लेकर हिचकिचाहट अब दूर हो जाएगी।#LargestVaccineDrive pic.twitter.com/gyvpPaj0JL
— Dr Harsh Vardhan (@drharshvardhan) March 1, 2021
Reason of Corona Virus Mutation in India
- On 16 January, India began its vaccination campaign against Covid-19, giving initial doses to around 2,00,000 health workers, and reminded them to return on 13 February for their second shots.
- But when that date took place, less than 8,000 returned – 4% of the total.
- By the morning of 15 February, the ratio had improved, but just 24,561 health workers received the second shot out of 2,24,301 who wanted to receive it, or just over 10%.
- This is a problem – and not just for India. If people skip their second dose, or even if they delay the dose beyond the recommended timeframe, it makes corona virus more likely to rebalance themselves – in such a way as to mutate mutually. Like- TB
- Which may lend to the high resistance to vaccination we have.
- If that mutant, resistant form spreads, a year’s worth of vaccine research may be overcome by a new wave of disease “Which would be dangerous for the World”.
Who should avoid Bharat Biotech’s Covaxin?
- People who are immune-compromised or those who are on any medication that affects immunity cannot take Bharat Biotech’s Covaxin.
- Those who have any history of allergies or anyone having a fever or slight temperature should avoid Bharta Biotech’s Covaxin.
- Having Blod disorder, women who are pregnant or breastfeeding cannot take Bharat Bioteccchg Covaxin.
- Anyone who has taken another corona vaccine or having some health issues can’t take Bharat Biotech Covaccine.
- Because Bharat Biotech hasn’t trial their vaccine on any of the above mentioned in the list.
- Registration link for Covaxin– www.cowin.gov.in.
COVAXIN shows high safety, immunogenicity during phase 1 clinical trial: Lancet journal https://t.co/p8SmFVsSFw
— ICMR (@ICMRDELHI) January 22, 2021
Who should avoid Serum Institutes’ Covishield?
- Anyone who is allergic to any ingredient present in Covishield (Ingredients of Covishiled is – L-Histidine, L-Histidine hydrochloride monohydrate, Disodium edetate dehydrate (EDTA) and Water for Injection)
- Serum Institute said if the first dose of Covishield causes service infection avoids the second dose of it.
- Under 18 women who are pregnant or breastfeeding should avoid Covishield.
Both Bharat Biotech and Serum Institute have clearly said that anyone who is taking vaccines should tell the health care first about any health issue, existing medical conditions any allergies, or under any sort of medications that effects the immunity before taking the vaccine.
Side Effects of Bharat Biotech and Covishield Vaccine
Well, Bharat Biotech and Serum Institue have listed a sort of minor side effects like–
- Swelling, Pain, Redness, and Itching where the Injection is Administered.
- Stiffness in the upper arm where the injection has been administered or weakness in the injected arm.
- Body ache, Headache, Fever, Fatigue, Rashes, Nausea, or even Vomiting have been listed as the side effects of the vaccine.
Vaccination for Everyone above18
- Center rejects demand for vaccination above 18 years because it will prioritize the vulnerable groups.
- A new study conducted by Tata Consultancy Services (TCS) and the National Institute of Industrial Engineering (NITIE) recommends vaccines be given to all people over the age of 18 from 15 April.
- Even if India opens up COVID-19 vaccination for everyone above 18 years of age, it will take another six to seven months to vaccinate the entire country at the rate of 2.5 million doses a day.
The need to cover more of the Indian population TCS and NITIE recommendation
- TCS and NITIE suggest that India should prioritize and intensify vaccination for the 130 districts that were identified as the ones ‘Red Zone’ during the first wave of the epidemic.
- The report said “Once vaccinations are open to all people over the age of 18, about 230 million people – in these 130 districts – require a vaccination at the rate of 2.5 million per day,”
- Beyond these 130 districts, it would take another six to seven months to vaccinate the remaining population of about 490 million people over the age of 18.
PM Narendra Modi has taken his second dose of Covid Vaccine at AIIMS today and urges others to get it soon.
“Got my second dose of the COVID-19 vaccine at AIIMS today. Vaccination is among the few ways we have, to defeat the virus. If you are eligible for the vaccine, get your shot soon,” PM Modi Tweeted
Got my second dose of the COVID-19 vaccine at AIIMS today.
Vaccination is among the few ways we have, to defeat the virus.
If you are eligible for the vaccine, get your shot soon. Register on https://t.co/hXdLpmaYSP. pic.twitter.com/XZzv6ULdan
— Narendra Modi (@narendramodi) April 8, 2021
For daily news updates related to finance, business and sports keep following our portal Daily News Capsule
Nikita Dhyani is a passionate writer. She basically writes on Health, Finance, and Politics related topics. She has explored many areas of interest and is being a part of the journalism industry.